Skip to content

Neogen NEOG Debt-to-equity

Debt-to-equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.8×+0.1×
Idexx Laboratories logo
Idexx LaboratoriesIDXX
0.4×-0.1×
Zoetis logo
ZoetisZTS
3.1×+1.6×
Revvity logo
RevvityRVTY
0.5×+0.1×
TEC
Bio-TechneTECH
0.1×-0.1×
Agilent Technologies logo
Agilent TechnologiesA
0.5×-0.1×

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

Based on the most recent quarter.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's debt-to-equity?
Neogen (NEOG) reported debt-to-equity of 0.4× in Q4 2025.
How has Neogen's debt-to-equity changed year-over-year?
Neogen's debt-to-equity increased by 12.4% year-over-year, from 0.3× to 0.4×.
What is the long-term trend for Neogen's debt-to-equity?
Over 4 years (2021 to 2025), Neogen's debt-to-equity has grown at a 248.4% compound annual growth rate (CAGR), from 0× to 0.4×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.